Neutrophil/Leukemia‐Tropic Dual‐Drug Nanomedicine Potentiates the Treatment of Acute Myeloid Leukemia
Advanced Materials · 2026-01 · 38 (6)
DOI: 10.1002/adma.202512635 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 10.11.2025. Verfasst von Shujing Yue und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioinspired Interfacial Materials Science, and Biomedical Polymers Laboratory, College of Chemistry, Chemical Engineering and…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Neutrophils, Nanomedicine, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Acute myeloid leukemia (AML) poses severe clinical challenges due to its heterogeneity and the scattered nature of therapeutic targets. Moreover, suboptimal drug delivery to the bone marrow, combined with the protective effects of the niche that shelters residual leukemia cells, frequently underlies chemotherapy failure and relapse. Here, a neutrophil/leukemia‐tropic polymersome vincristine/volasertib dual‐drug nanoformulation (NLP‐Vi/Vo) is reported to selectively bind to leukemia cells and neutrophils, and to ratiometrically release clinical chemotherapeutics and a polo‐like kinase 1 inhibitor, thereby potentiating the treatment of AML. NLP‐Vi/Vo induces synergistic anti‐AML effects by sensitizing AML to chemotherapy, and homes to bone marrow by hitchhiking on neutrophils, cooperatively depleting leukemia in both the bloodstream and bone marrow. NLP‐Vi/Vo shows excellent therapeutic efficacy in malignant murine AML and human AML xenograft models. Collectively, neutrophil/leukemia‐directing dual‐drug nanomedicines offer a promising treatment strategy for AML.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioinspired Interfacial Materials Science, and Biomedical Polymers Laboratory, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou, 215123, P. R. China.
- Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, 215123, P. R. China.
- Department of Orthopaedic Surgery, Orthopaedic Institute, The First Affiliated Hospital, Soochow University, Suzhou, 215007, P. R. China.
- College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, P. R. China.
ORCID-Profile: Zhiyuan Zhong
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yue, S., Zhai, Z., An, J., Sun, H., Li, J., Zhao, C., Xu, Y., & Zhong, Z. (2026). Neutrophil/Leukemia‐Tropic Dual‐Drug Nanomedicine Potentiates the Treatment of Acute Myeloid Leukemia. Advanced Materials, 38(6). https://doi.org/10.1002/adma.202512635
Vancouver
Yue S, Zhai Z, An J, Sun H, Li J, Zhao C, et al. Neutrophil/Leukemia‐Tropic Dual‐Drug Nanomedicine Potentiates the Treatment of Acute Myeloid Leukemia. Advanced Materials. 2026;38(6). doi:10.1002/adma.202512635
BibTeX
@article{Yue2026,
author = {Yue, Shujing and Zhai, Zhenzhen and An, Jingnan and Sun, Huanli and Li, Jiaying and Zhao, Cenzhu and Xu, Yang and Zhong, Zhiyuan},
title = {Neutrophil/Leukemia‐Tropic Dual‐Drug Nanomedicine Potentiates the Treatment of Acute Myeloid Leukemia},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {6},
doi = {10.1002/adma.202512635}
}
EUVIMED